Journal of Arrhythmia · 2015 · 79 citations · 20 references
MedicineCardiologySurgeryCardiothoracic SurgeryHemodynamic ManagementInterventional CardiologyAnticoagulant ManagementAtrial FibrillationCardiac CatheterizationCatheter AblationLeft Atrial Appendage ClosureLeft Atrial AblationLeft Atrial Appendage Occlusion DevicesLeft Atrial Appendage ThrombosisPulmonary Vein IsolationRhythm Control TherapySystemic AnticoagulationTherapeutic AnticoagulationWatchman Device
BACKGROUND: Patients with atrial fibrillation (AF) may benefit from undergoing concomitant interventions of left atrial catheter ablation and device occlusion of the left atrial appendage (LAA) as a two-pronged strategy for rhythm control and stroke prevention. We report on the outcome of combined procedures in a single center case series over a 5-year timeframe. METHODS: Ninety-eight patients with non-valvular AF and a mean CHA2DS2-VASc score 2.6±1.0 underwent either first time, or redo pulmonary vein isolation (PVI) procedures, followed by successful implant of a Watchman® device. RESULTS: All procedures were generally uncomplicated with a mean case time of 213±40 min. Complete LAA occlusion was achieved at initial implant in 92 (94%) patients. Satisfactory LAA occlusion was achieved in 100% of patients at 12 months, with a complete LAA occlusion rate of 86%. All patients discontinued oral anticoagulation. Persistent late peri-device leaks were more frequently associated with device angulation or shoulder protrusion, and were associated with a significantly lower achieved device compression of 12±3% vs. 15±5% (p<0.01) than complete occlusion. One ischemic stroke was recorded over a mean follow-up time of 802±439 days. Twelve months׳ freedom from detectable AF was achieved in 77% of patients. CONCLUSIONS: Combined procedures of catheter ablation for AF and Watchman® LAA implant appear to be feasible and safe, with excellent rates of LAA occlusion achieved and an observed stroke rate of 0.5% per year during mid-term follow-up. Incomplete occlusion was associated with lower achieved device compression and was more frequently associated with suboptimal device position.
20
A. John Camm, Paulus Kirchhof, Gregory Y.H. Lip et al. · European Heart Journal · 2010 · 5.9K citations · Full text
David R. Holmes, Vivek Y. Reddy, Zoltan G. Turi et al. · The Lancet · 2009 · 2.2K citations
David R. Holmes, Saibal Kar, Matthew J. Price et al. · Journal of the American College of Cardiology · 2014 · 1.8K citations
Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation
Vivek Y. Reddy, Horst Sievert, Jonathan L. Halperin et al. · JAMA · 2014 · 982 citations